title: Dyslipidemia in renal disease: causes, consequences and treatment.
abstract: The prevalence of chronic renal insufficiency and its complications, including dyslipidemia, is increasing. Although the characteristics of dyslipidemia in chronic renal insufficiency and its pathophysiology are well known, its cardiovascular and renal impact and the most effective therapeutic approach are poorly defined.
authors.affiliation: Endocrinology Department, Hospital de São João-EPE, Portugal. joanamesquita1@gmail.com
authors.forename: Joana
authors.initials: J
authors.lastname: Mesquita
authors.forename: Ana
authors.initials: A
authors.lastname: Varela
authors.forename: José Luís
authors.initials: JL
authors.lastname: Medina
mesh_terms: D002318:Cardiovascular Diseases / Q000209:etiology / Q000628:therapy; D050171:Dyslipidemias / Q000209:etiology* / Q000628:therapy*; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use; D051436:Renal Insufficiency, Chronic / Q000150:complications* / Q000378:metabolism
chemical_list: D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors